Berenice Mareen Lang

Suggest Changes
  • Citations Per Year
Learn More
Currently interferon alfa-2b (IFNα-2b) is an approved adjuvant drug for high-risk melanoma patients that leads to an improvement in disease-free survival (DFS). However, it is unclear whether it also(More)
  • 1